As per 2016 WHO CNS tumor classification, all LGG IDH mutant samples that have 1p/19q codeletion are designated as oligodendroglioma and those with intact 1p/19q loci and enriched for TP53 mutation/ATRX loss are designated as diffuse astrocytoma. This evidence concerns the gene IDH1 and central nervous system neoplasm.